These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 9773738)
1. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Brunelle BL; Llewelyn J; Anderson JH; Gale EA; Koivisto VA Diabetes Care; 1998 Oct; 21(10):1726-31. PubMed ID: 9773738 [TBL] [Abstract][Full Text] [Related]
2. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group. Heller SR; Amiel SA; Mansell P Diabetes Care; 1999 Oct; 22(10):1607-11. PubMed ID: 10526722 [TBL] [Abstract][Full Text] [Related]
3. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus. Burge MR; Waters DL; Holcombe JH; Schade DS J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507 [TBL] [Abstract][Full Text] [Related]
4. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight. Mohn A; Matyka KA; Harris DA; Ross KM; Edge JA; Dunger DB Diabetes Care; 1999 Jan; 22(1):27-32. PubMed ID: 10333899 [TBL] [Abstract][Full Text] [Related]
5. Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group. Holleman F; Schmitt H; Rottiers R; Rees A; Symanowski S; Anderson JH Diabetes Care; 1997 Dec; 20(12):1827-32. PubMed ID: 9405901 [TBL] [Abstract][Full Text] [Related]
6. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients. Ahmed AB; Home PD Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967 [TBL] [Abstract][Full Text] [Related]
7. Meal composition is a determinant of lispro-induced hypoglycemia in IDDM. Burge MR; Castillo KR; Schade DS Diabetes Care; 1997 Feb; 20(2):152-5. PubMed ID: 9118763 [TBL] [Abstract][Full Text] [Related]
8. Treatment of type 1 diabetes with insulin lispro during Ramadan. Kadiri A; Al-Nakhi A; El-Ghazali S; Jabbar A; Al Arouj M; Akram J; Wyatt J; Assem A; Ristic S Diabetes Metab; 2001 Sep; 27(4 Pt 1):482-6. PubMed ID: 11547222 [TBL] [Abstract][Full Text] [Related]
9. Italian multicentre study of intensive therapy with insulin lispro in 1184 patients with Type 1 diabetes. Valle D; Santoro D; Bates P; Scarpa L; Diabetes Nutr Metab; 2001 Jun; 14(3):126-32. PubMed ID: 11476359 [TBL] [Abstract][Full Text] [Related]
10. Insulin lispro: its role in the treatment of diabetes mellitus. Campbell RK; Campbell LK; White JR Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409 [TBL] [Abstract][Full Text] [Related]
11. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group. Anderson JH; Brunelle RL; Keohane P; Koivisto VA; Trautmann ME; Vignati L; DiMarchi R Arch Intern Med; 1997 Jun; 157(11):1249-55. PubMed ID: 9183237 [TBL] [Abstract][Full Text] [Related]
12. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. Anderson JH; Brunelle RL; Koivisto VA; Pfützner A; Trautmann ME; Vignati L; DiMarchi R Diabetes; 1997 Feb; 46(2):265-70. PubMed ID: 9000704 [TBL] [Abstract][Full Text] [Related]
13. Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes. Launay B; Zinman B; Tildesley HD; Strack T; Chiasson JL Diabetes Care; 1998 Oct; 21(10):1627-31. PubMed ID: 9773721 [TBL] [Abstract][Full Text] [Related]
14. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro. Ahmed AB; Mallias J; Home PD Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613 [TBL] [Abstract][Full Text] [Related]
15. Optimal provision of daytime NPH insulin in patients using the insulin analog lispro. Ahmed AB; Home PD Diabetes Care; 1998 Oct; 21(10):1707-13. PubMed ID: 9773735 [TBL] [Abstract][Full Text] [Related]
16. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus. Wilde MI; McTavish D Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963 [TBL] [Abstract][Full Text] [Related]
17. Treatment with the insulin analogue lispro in children and adolescents with type 1 diabetes mellitus: evaluation over a 3-year period. García L; Lamas C; Tuset MJ; Alonso M; Barrio R Diabetes Nutr Metab; 2002 Feb; 15(1):7-13. PubMed ID: 11942742 [TBL] [Abstract][Full Text] [Related]
18. Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes. Garg SK; Carmain JA; Braddy KC; Anderson JH; Vignati L; Jennings MK; Chase HP Diabet Med; 1996 Jan; 13(1):47-52. PubMed ID: 8741812 [TBL] [Abstract][Full Text] [Related]
19. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro). Rabasa-Lhoret R; Bourque J; Ducros F; Chiasson JL Diabetes Care; 2001 Apr; 24(4):625-30. PubMed ID: 11315820 [TBL] [Abstract][Full Text] [Related]
20. Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin. Ferguson SC; Strachan MW; Janes JM; Frier BM Diabetes Metab Res Rev; 2001; 17(4):285-91. PubMed ID: 11544612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]